DUBLIN--(BUSINESS WIRE)--The "Coagulation Analyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The global coagulation analyzer market was worth US$ 3.6 Billion in 2018 and is expected to reach a value of US$ 6.2 Billion by 2024, registering a CAGR of 9.2% during 2019-2024.
Coagulation, also known as hematology, is a process that enables the blood to create a clot to heal a wound. Physicians primarily use coagulation analyzers for quantifying and classifying blood cells. Different types of coagulation tests, such as PT, APTT, ACT, etc., are carried out for assessing blood clotting function in patients.
Most of the hematology analyzers are capable of providing information about hemoglobin in red blood cells (RBCs), corpuscular data, platelet counts and hematocrit levels. However, some new machines have been developed to measure two specialized cell types, which include nucleated RBCs and immature white cells. At present, coagulation analyzers are experiencing a rise in their demand on account of consistent growth in the population suffering from blood disorders and lifestyle diseases.
Over the past decade, rapid advancements in technology and the introduction of new coagulation analyzer tests have led to an increase in the quality and effciency of hemostasis laboratories. Some of the modern complex coagulators also possess high throughput, flexibility and reliability. Other than this, they provide improved accuracy and precision, and easy-to-use advanced software provided with in-built graphs and calibration curves.
Moreover, there has been a significant rise in the prevalence of cardiac diseases and blood disorders, which has created the need for improved coagulation analyzers across the globe. Besides this, the sales of coagulation analyzers is positively being influenced by the increasing number of hospitals, diagnostic centers and research institutes established worldwide.
Key Questions Answered in This Report:
- How has the global coagulation analyzer market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global coagulation analyzer industry?
- What is the breakup of the market based on the testing type?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the technology type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the global coagulation analyzer industry?
- What are the key driving factors and challenges in the global coagulation analyzer industry?
- What is the structure of the global coagulation analyzer industry and who are the key players?
- What is the degree of competition in the global coagulation analyzer industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Coagulation Analyzer Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Testing Type
5.4 Market Breakup by Product Type
5.5 Market Breakup by Technology Type
5.6 Market Breakup by End User
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Testing Type
6.1 Prothrombin Time Testing (PT)
6.2 Fibrinogen Testing
6.3 Activated Partial Thromboplastin Time Testing (APTT)
6.4 Activated Clotting Time Testing (ACT)
6.5 D-Dimer Testing
6.6 Platelet Function Testing
6.7 Anti-Factor Xa Testing
6.8 Others
7 Market Breakup by Product Type
7.1 Instruments/Analyzers
7.1.1 Market Trends
7.1.2 Market Breakup by Type
7.1.2.1 Automated Analyzers
7.1.2.2 Semi-Automated Analyzers
7.1.2.3 Manual Analyzers
7.1.3 Market Forecast
7.2 Reagents
7.3 Consumables
7.4 Others
8 Market Breakup by Technology Type
8.1 Optical Technology
8.2 Mechanical Technology
8.3 Electrochemical Technology
8.4 Others
9 Market Breakup by End User
9.1 Clinical Laboratories
9.2 Diagnostic Centers
9.3 Hospitals
9.4 Others
10 Market Breakup by Region
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Alere Inc.
15.3.2 Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
15.3.3 Nihon Kohden Corporation
15.3.4 Sysmex Corporation
15.3.5 Siemens Healthcare (AG)
15.3.6 Thermo Fisher Scientific Inc.
15.3.7 Helena Laboratories
15.3.8 Diagnostica Stago Sas
15.3.9 Instrumentation Laboratory (Werfen Group)
15.3.10 International Technidyne Corporation (ITC)
For more information about this report visit https://www.researchandmarkets.com/r/i9agf6
